Pharmaceutical

FDA approves IND application for Everest’s cancer vaccine

The FDA has granted approval for the IND application of Everest Medicines’ tumour-associated antigen (TAA) vaccine, EVM14.

Mar 25, 2025 - 06:00
FDA approves IND application for Everest’s cancer vaccine
The FDA has granted approval for the IND application of Everest Medicines’ tumour-associated antigen (TAA) vaccine, EVM14.
Read the original article

Tags:

Previous Article

Augustine secures $85m to advance Charcot-Marie-Tooth candidate

Next Article

AstraZeneca to invest $2.5bn in R&D centre in China

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: Listen: Two medical residents debate their hospital’s unionization drive

Opinion: Listen: Two medical residents debate their hos...

May 3, 2023

Opinion: The CDC’s new, relaxed Covid isolation guidance makes perfect sense

Opinion: The CDC’s new, relaxed Covid isolation guidanc...

Mar 6, 2024

STAT+: White House drug shortage task force held rare in-person meeting with industry

STAT+: White House drug shortage task force held rare i...

Aug 3, 2023